loading

Ovid Therapeutics Inc Azioni (OVID) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
71.05%
0.13
0.076 0.173 0.169 0.148
Operating Expenses
17.43%
12.68
10.80 13.40 20.69 17.57
Benefits Costs and Expenses
11.11%
10.37
9.329 14.18 -8.352 11.84
Costs And Expenses
11.11%
10.37
9.329 14.18 -8.352 11.84
Operating Income/Loss
17.05%
-12.55
-10.72 -13.23 -20.52 -17.42
Income/Loss From Continuing Operations Before Tax
10.61%
-10.23
-9.253 -14.01 8.521 -11.69
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
10.61%
-10.23
-9.253 -14.01 8.521 -11.69
Net Income/Loss
10.61%
-10.23
-9.253 -14.01 8.521 -11.69
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
100.00%
-
-0.458 - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Capitalizzazione:     |  Volume (24 ore):